This brand name is authorized in Cyprus, Singapore
The drug STORILAT contains one active pharmaceutical ingredient (API):
1
Carbamazepine
UNII 33CM23913M - CARBAMAZEPINE
|
Carbamazepine is a derivative of dibenzazepine. It belongs to the pharmaceutical class of antiepileptic, neurotropic and psychotropic drugs. Carbamazepine helps control the transmission of messages from the brain to the muscles. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
STORILAT Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N03AF01 | Carbamazepine | N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AF Carboxamide derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: SG | Health Sciences Authority | Identifier(s): 05583P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.